Jan Davidson

Jan Davidson

Company: Wugen Inc.

Job title: Chief Medical Officer


Fireside Chat: An Update on Novel Cellular Immunotherapies to Tackle Head and Neck Cancer 3:00 pm

Sharing rationale for targeting neoantigens for anti-tumor vaccination Summarizing therapeutic development of neoantigen vaccination for oncology to date Overview results of neoantigen vaccination application for H&N tumors Outlining next steps to optimize neoantigen vaccination for head and neck tumorsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.